Price $2.19 |
Market Cap
108.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.28
|
P/S
1.33
|
Dividend %
-
|
|
P/CF
119.6
|
P/FCF
-
|
Op. Cash Flow
-24.8K
|
FCF
-0.5
|
|
Op. Margin
-42.10%
|
Net Margin
-43.40%
|
ROE
-72.50%
|
ROI
-25.50%
|
|
ROA
-39.00%
|
EPS Growth
-
|
Current Ratio
2.2
|
Debt/Equity
7.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Interpace Biosciences Inc (IDXG) | $1.29 | - | - | 11.2M | Strong Buy |
| Hexo Corp (HEXO) | $0.93 | - | - | 57.2M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $1.60 | - | - | 6.5M | Strong Buy |
| Mallinckrodt PLC (MNK) | $1.41 | - | - | 34.1M | Strong Buy |
| Escalon Medical Corp (ESMC) | $0.28 | - | - | 1.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
